Q32 Bio Inc. (LON: 0T6G)
London
· Delayed Price · Currency is GBP · Price in USD
3.079
-0.271 (-8.09%)
At close: Jan 31, 2025
Q32 Bio Employees
Q32 Bio had 37 employees as of December 31, 2023.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
-254.40K GBP
Profits / Employee
-1.05M GBP
Market Cap
29.69M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 37 | - | - |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Q32 Bio News
- 7 weeks ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 7 weeks ago - Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
- 7 weeks ago - Q32 Bio Crashes 67% On A 'Messy' Update In Eczema, Alopecia Treatment - Investor's Business Daily
- 7 weeks ago - Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program - PRNewsWire
- 3 months ago - Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - PRNewsWire
- 3 months ago - Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - PRNewsWire
- 5 months ago - Q32 Bio to Participate in Upcoming September Investor Conferences - PRNewsWire